DNER and cancer: Additionally, various studies have utilized BET inhibitors in combination with targeted small-molecule inhibitors, immune checkpoint inhibitors, and other epigenetic-based therapies, indicating a future for BET inhibitors as useful component of combinatorial approaches to cancer therapy [45].